HECA

Musk approaches brain chip startup Synchron over deal amid Neuralink delays

Musk approaches brain chip startup Synchron over deal amid Neuralink delays

Leave a Comment / Business / By

Tesla CEO Elon Musk watches as he visits the construction site of Tesla’s gigafactory in Gruenheide, near Berlin, Germany, May 17, 2021. REUTERS/Michele Tantussia Register now for FREE unlimited access to Reuters.com Register Aug 19 (Reuters) – Elon Musk has announced brain chip implant developer Synchron Inc. approached about a potential investment as his own …

Musk approaches brain chip startup Synchron over deal amid Neuralink delays Read More »

Bluebird's $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval

Bluebird’s $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval

Leave a Comment / Business / By

Signage is on display outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, Aug. 29, 2020. REUTERS/Andrew Kelly/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved bluebird bios (BLUE.O) gene therapy for patients with a rare …

Bluebird’s $2.8M Gene Therapy Becomes Most Expensive Drug After U.S. Approval Read More »